Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
81,126,749
-
Share change
-
-2,773,713
-
Total reported value
-
$6,440,150,598
-
Put/Call ratio
-
92%
-
Price per share
-
$79.32
-
Number of holders
-
685
-
Value change
-
-$199,363,718
-
Number of buys
-
300
-
Number of sells
-
303
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q3 2022
As of 30 Sep 2022,
SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by
685 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
81,126,749 shares.
The largest 10 holders included
MORGAN STANLEY, BANK OF AMERICA CORP /DE/, GOLDMAN SACHS GROUP INC, CITIGROUP INC, UBS Group AG, JPMORGAN CHASE & CO, BNP PARIBAS ARBITRAGE, SNC, TORONTO DOMINION BANK, Clal Insurance Enterprises Holdings Ltd, and Avidity Partners Management LP.
This page lists
692
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.